Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 22, Number 27, 2015

Articles

Free Content Meet Our Editorial Board Member:
pp. 3109-3109(1)
Author: Li, Wei

Favourites:
ADD

Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB): From Biological Insight to Inhibitors
pp. 3110-3132(23)
Authors: Fanzani, Luisa; Porta, Federica; Meneghetti, Fiorella; Villa, Stefania; Gelain, Arianna; Lucarelli, Anna P.; Parisini, Emilio

Favourites:
ADD

Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets
pp. 3133-3161(29)
Authors: Felipe dos Santos Fernandes, Guilherme; Hartmann Jornada, Paula, Daniela; de Souza, Carolina; Man Chin, Chung; Rogerio Pavan, Fernando; Leandro dos Santos, Jean

Favourites:
ADD

Nalmefene: A Novel Drug for an Old Disorder
pp. 3162-3168(7)
Authors: Marazziti, Donatella; Presta, Silvio; Baroni, Stefano; Mungai, Francesco; Piccinni, Armando; Mucci, Federico; Dell128;â„¢Osso, Liliana

Favourites:
ADD

Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer’s Disease
pp. 3169-3184(16)
Authors: Rozpedek, Wioletta; Markiewicz, Lukasz; Alan Diehl, J.; Pytel, Dariusz; Majsterek, Ireneusz

Favourites:
ADD

The Interest of Folic Acid in Targeted Photodynamic Therapy
pp. 3185-3207(23)
Authors: Stallivieri, Aurelie; Baros, Francis; Jetpisbayeva, Gulim; Myrzakhmetov, Bauyrzhan; Frochot, Celine

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content